Particle-mediated DNA vaccine delivery to the skin (Q35790864)

10 August 2017

1 reference

title

Particle-mediated DNA vaccine delivery to the skin (English)

1 reference

10 August 2017

Joel R Haynes

1

1 reference

PubMed ID

15174971

10 August 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Expert Opinion on Biological Therapy

10 August 2017

1 reference

10 August 2017

4

1 reference

10 August 2017

6

1 reference

10 August 2017

889-900

1 reference

Stable Transformation of Soybean Callus by DNA-Coated Gold Particles

10 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Genetic immunization is a simple method for eliciting an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Gene gun-mediate DNA vaccination against foot-and-mouth disease virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Immune responses to hepatitis B virus surface and core antigens in mice, monkeys, and pigs after Accell particle-mediated DNA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Safety and immune responses to a DNA-based human immunodeficiency virus (HIV) type I env/rev vaccine in HIV-infected recipients: follow-up data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Immune responses in baboons vaccinated with HIV-2 genetic expression libraries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Protection against mycoplasma infection using expression-library immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Evaluation of SIV library vaccines with genetic cytokines in a macaque challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Genetic to genomic vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Identification of a protective antigen of Coccidioides immitis by expression library immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Quantitative analysis of the immunopotency of genetically transfected dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Induction of immunodeficiency virus-specific immune responses in rhesus monkeys following gene gun-mediated DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Gene gun-based co-immunization of merozoite surface protein-1 cDNA with IL-12 expression plasmid confers protection against lethal Plasmodium yoelii in A/J mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

The protective efficacy of MSP4/5 against lethal Plasmodium chabaudi adami challenge is dependent on the type of DNA vaccine vector and vaccination protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Intra-epithelial vaccination with COPV L1 DNA by particle-mediated DNA delivery protects against mucosal challenge with infectious COPV in beagle dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Intracutaneous vaccination of rabbits with the cottontail rabbit papillomavirus (CRPV) L1 gene protects against virus challenge .

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Evaluation of tick-borne encephalitis DNA vaccines in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

One-time gene gun or intramuscular rabies DNA vaccination of non-human primates: comparison of neutralizing antibody responses and protection against rabies virus 1 year after vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Rabies DNA vaccination of non-human primates: post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Effect of CpG methylation on isotype and magnitude of antibody responses to influenza hemagglutinin-expressing plasmid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

T helper 2 immunity to hepatitis B surface antigen primed by gene-gun-mediated DNA vaccination can be shifted towards T helper 1 immunity by codelivery of CpG motif-containing oligodeoxynucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

The immune response to hepatitis B vaccine in humans: inheritance patterns in families

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Regulation of DNA-raised immune responses by cotransfected interferon regulatory factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Immunomodulation by apoptosis-inducing caspases for an influenza DNA vaccine delivered by gene gun.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Gene gun immunization in a preclinical model is enhanced by B7 targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Induction of CD8+ T cells using heterologous prime-boost immunisation strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.889

21 January 2018

Identifiers

DOI

10.1517/14712598.4.6.889

1 reference

10 August 2017

1 reference

PubMed ID

15174971